GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AK Medical Holdings Ltd (HKSE:01789) » Definitions » Altman Z-Score

AK Medical Holdings (HKSE:01789) Altman Z-Score : 6.79 (As of Dec. 13, 2024)


View and export this data going back to 2017. Start your Free Trial

What is AK Medical Holdings Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 7.04 is strong.

AK Medical Holdings has a Altman Z-Score of 6.79, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for AK Medical Holdings's Altman Z-Score or its related term are showing as below:

HKSE:01789' s Altman Z-Score Range Over the Past 10 Years
Min: 7.04   Med: 11.66   Max: 17.58
Current: 7.04

During the past 10 years, AK Medical Holdings's highest Altman Z-Score was 17.58. The lowest was 7.04. And the median was 11.66.


AK Medical Holdings Altman Z-Score Historical Data

The historical data trend for AK Medical Holdings's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AK Medical Holdings Altman Z-Score Chart

AK Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.16 17.58 7.93 13.04 8.16

AK Medical Holdings Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 13.04 - 8.16 -

Competitive Comparison of AK Medical Holdings's Altman Z-Score

For the Medical Devices subindustry, AK Medical Holdings's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AK Medical Holdings's Altman Z-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AK Medical Holdings's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where AK Medical Holdings's Altman Z-Score falls into.



AK Medical Holdings Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

AK Medical Holdings's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.4917+1.4*0.4646+3.3*0.0774+0.6*8.2138+1.0*0.3643
=6.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was HK$3,285 Mil.
Total Current Assets was HK$2,160 Mil.
Total Current Liabilities was HK$545 Mil.
Retained Earnings was HK$1,526 Mil.
Pre-Tax Income was HK$253 Mil.
Interest Expense was HK$-1 Mil.
Revenue was HK$1,196 Mil.
Market Cap (Today) was HK$5,490 Mil.
Total Liabilities was HK$668 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(2160.012 - 544.891)/3284.644
=0.4917

X2=Retained Earnings/Total Assets
=1526.063/3284.644
=0.4646

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(252.791 - -1.408)/3284.644
=0.0774

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=5490.335/668.431
=8.2138

X5=Revenue/Total Assets
=1196.443/3284.644
=0.3643

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

AK Medical Holdings has a Altman Z-Score of 6.79 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


AK Medical Holdings  (HKSE:01789) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


AK Medical Holdings Altman Z-Score Related Terms

Thank you for viewing the detailed overview of AK Medical Holdings's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


AK Medical Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 10 Baifuquan Road, 2nd Floor, Xingye Mansion, Changping District Science and Technology Park, Beijing, CHN, 102200
AK Medical Holdings Ltd is an investment holding company which designs, develops, produces, and markets orthopedic joint implants and related products. The company's geographical segments include China and the United Kingdom. It derives the majority of revenue from China. The company offers off-the-shelf products, such as knee replacement and hip replacement implants; and 3D-printed products, including 3D-printed hip replacement implants, spinal interbody cages, and artificial vertebral bodies.
Executives
Li Zhijiang
Trident Trust Company (hk) Limited
Ximalaya Limited
The Goldman Sachs Group, Inc. 2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd. 2102 Investment manager
Suntop Limited 2101 Beneficial owner
Zhang Chaoyang 2307 Founder of a discretionary trust who can infl
Bamboo Group Management Limited 2201 Interest of corporation controlled by you
Zhang Bin 2202 Interest of your spouse
Rainbow Holdings Limited 2201 Interest of corporation controlled by you
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner
Orbimed Advisors Ii Limited
Orbimed Asia Gp Ii, L.p.
Orbimed Asia Partners Ii, L.p.

AK Medical Holdings Headlines

No Headlines